Suven Lifesciences can move back to 55-60 levels: Devangvisaria.com
Devang Visaria, chief strategist, Devangvisaria.com, in a chat with ET Now talks about Suven Lifesciences.
By 
|
| Devang Visaria, chief strategist, Devangvisaria.com, in a chat with ET Now talks about Suven Lifesciences.
Is there anything that looks interesting in mid-cap pharma? There was news on Suven Lifesciences. There was recommendation coming in on Fortis. Apollo moved yesterday. Is there anything that you like?
Suven Lifesciences - if it makes a move past 37-38 - you could have a good move back to around 55-60 kind of levels. Till then it is likely to consolidate between 38 on the upside and 28 on the downside. So that becomes a good accumulation opportunity for Suven Lifesciences.
Is there anything that looks interesting in mid-cap pharma? There was news on Suven Lifesciences. There was recommendation coming in on Fortis. Apollo moved yesterday. Is there anything that you like?
Suven Lifesciences - if it makes a move past 37-38 - you could have a good move back to around 55-60 kind of levels. Till then it is likely to consolidate between 38 on the upside and 28 on the downside. So that becomes a good accumulation opportunity for Suven Lifesciences.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
